News: cancer

Leading cancer researcher joins SAiGENCI

Melissa Davis smiles at the camera.

Cancer research expert Professor Melissa Davis has been appointed as Program Leader, Cancer Systems Biology at the South Australian immunoGENomics Cancer Institute (SAiGENCI).

[Read more about Leading cancer researcher joins SAiGENCI]

Medical research funding boost has wide impact

AHMS building

³ÉÈË´óƬ experts have been awarded more than $1.9 million to pursue medical research that will improve the lives of people such as young Aboriginal women, high-risk COVID-19 groups and cancer sufferers.

[Read more about Medical research funding boost has wide impact]

Cancer treatment ‘brain-gain’ for South Australia

Professor Christopher Sweeney

South Australian patients with cancer will benefit from world-class cancer research and new treatments with the appointment of three globally-lauded scientists to the ³ÉÈË´óƬ’s South Australian immunoGENomics Cancer Institute (SAiGENCI).

[Read more about Cancer treatment ‘brain-gain’ for South Australia]

State-of-the-art Cancer Institute to deliver world-leading research and treatment for South Australians

SAiGENCI

World-leading patient care, cutting-edge cancer diagnoses and treatments – including genomic and immune-based technologies – combined with ground-breaking research collaborations, will be the focus of a new cancer institute in South Australia.

[Read more about State-of-the-art Cancer Institute to deliver world-leading research and treatment for South Australians]

Starving gut bacteria to improve chemotherapy outcomes

Dr Hannah Wardill

Fasting before chemotherapy drastically increases the number and diversity of bacteria found in the gut and can improve treatment outcomes, a new study by ³ÉÈË´óƬ researchers has found. 

[Read more about Starving gut bacteria to improve chemotherapy outcomes ]

$1.62 million for rare cancer research

Image of blood vials in a laboratory

A ³ÉÈË´óƬ and SAHMRI study to test new treatments for a rare and neglected blood cancer, which has no known effective treatment, has been awarded $1,619,122 from the Federal Government’s Medical Research Future Fund (MRFF).

[Read more about $1.62 million for rare cancer research]

Partnership to revolutionise cancer diagnosis

Women working in science laboratory

The ³ÉÈË´óƬ has partnered with medical technology company Sienna Cancer Diagnostics in an exclusive worldwide licencing agreement to develop a unique cancer probe with the potential to detect a sugar molecule only present in cancer cells.

[Read more about Partnership to revolutionise cancer diagnosis]

United front to Beat Cancer

Doctor looking in microscope

Two up-and-coming young researchers from the ³ÉÈË´óƬ and SAHMRI are major beneficiaries of the latest round of Cancer Council SA’s Beat Cancer Project funding.

[Read more about United front to Beat Cancer]

Major breakthrough for leukaemia treatment

An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia.

An international clinical trial involving Adelaide researchers has demonstrated the safety and efficacy of a next-generation treatment for people with chronic myeloid leukaemia (CML).

[Read more about Major breakthrough for leukaemia treatment]

Investment into incurable blood cancer research

At least a quarter of children with cerebral palsy have a clinically important genetic finding and 50 per cent of these will have immediate implications for their care, a new study from the ³ÉÈË´óƬ has found.

³ÉÈË´óƬ-led cancer researchers have received $600,000 to help drive rapid advancements in treatments for the incurable blood cancer, myeloma.

[Read more about Investment into incurable blood cancer research]

RSS News Feed